In this webinar we will explore the elements of genetic variant interpretation and evaluate the similarities and differences in germline and somatic genetic testing.

  • Summarize the methodologies and processes involved in germline variant classification.
  • Examine the clinical utility of germline variant classification.
  • Compare the methodologies used in genomic variant classification to those used in the germline space.
  • Evaluate genomic variant interpretation structure and how it impacts treatment decision making in oncology.

Hear from our speakers

Amelia Hodges PhD

Amelia is currently a Clinical Genomics Scientist on the Oncology team at Myriad Genetics, specializing in variant classification. She earned her PhD in Molecular Biosciences with a focus on chromatin biology and DNA repair. Her postdoctoral research focused on the regulation of gene expression in prostate cancer.

Scott George PhD

Clinical Genomics Scientist
Scott George is a Clinical Genomics Scientist at Myriad Genetics. His work focuses on identifying DNA- and RNA-based variants in patient’s cancer cells and connecting the genetic information to targeted drug therapies and clinical trials. He earned his PhD in Biology from Brigham Young University.